During the past decade, Wright State Physicians Dermatology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wright State Physicians Dermatology" are "Plaque Psoriasis" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Wright State Physicians Dermatology" in a lesser frequency.

Most popular intervention types in "Wright State Physicians Dermatology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Etanercept" (1 trials), "Ixekizumab" (1 trials), "Mirikizumab" (1 trials) and "Secukinumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wright State Physicians Dermatology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Wright State Physicians Dermatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Wright State Physicians Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wright State Physicians Dermatology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".